Study of Pembrolizumab and Radiotherapy in Liver Cancer

Clinical trial NCT03316872 · TERMINATED

Trial details

NCT number: NCT03316872
Sponsor: University Health Network, Toronto
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2018-02-15
Primary completion: 2024-02-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.